diagnostic software
Gene Expression Assay Shows Ability to Guide Targeted Treatment for Patients With Occult Cancers
Premium
Patients with cancers of unknown primary had more treatment options and better outcomes when care was informed by a 90-gene expression assay.
With recent response data galvanizing oncologists to expand access to anti-HER2 treatment, digital pathology firm Paige is ramping up efforts to create a companion test.
Invitae Acquiring Genosity for $200M; Investment Group Provides Firm $1.15B in Senior Notes
Invitae expects that Genosity's software and data management platform will allow it to quickly advance several oncology tests in development.
Washington University, BostonGene Expand Kidney Cancer Research Collaboration
WUSTL will evaluate BostonGene's software, which integrates data from NGS with immunofluorescence imaging to profile tumors and their microenvironments.
Sophia Genetics Gets CE-IVD Mark for Cancer Detection Solution
Sophia's STS molecular diagnostic application runs on top of the Sophia AI platform to detect and characterize genomic alterations in solid tumors.